[DPHARMA] QoQ TTM Result on 30-Jun-2014 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
26-Aug-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
30-Jun-2014 [#2]
Profit Trend
QoQ- -9.03%
YoY- 7.2%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Revenue 182,065 176,961 171,671 167,697 165,062 162,404 152,048 12.77%
PBT 47,513 46,490 41,729 39,496 42,396 40,177 40,017 12.13%
Tax -8,428 -8,009 -7,856 -7,519 -7,243 -6,690 -9,845 -9.85%
NP 39,085 38,481 33,873 31,977 35,153 33,487 30,172 18.85%
-
NP to SH 36,283 35,679 33,873 31,977 35,153 33,487 30,172 13.09%
-
Tax Rate 17.74% 17.23% 18.83% 19.04% 17.08% 16.65% 24.60% -
Total Cost 142,980 138,480 137,798 135,720 129,909 128,917 121,876 11.24%
-
Net Worth 205,045 192,951 187,531 179,145 190,050 181,818 179,017 9.48%
Dividend
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Div 25,682 25,682 24,291 24,291 24,289 24,289 20,128 17.65%
Div Payout % 70.79% 71.98% 71.71% 75.97% 69.10% 72.53% 66.71% -
Equity
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Net Worth 205,045 192,951 187,531 179,145 190,050 181,818 179,017 9.48%
NOSH 139,486 138,813 138,912 138,872 138,723 138,792 138,773 0.34%
Ratio Analysis
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
NP Margin 21.47% 21.75% 19.73% 19.07% 21.30% 20.62% 19.84% -
ROE 17.70% 18.49% 18.06% 17.85% 18.50% 18.42% 16.85% -
Per Share
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
RPS 130.52 127.48 123.58 120.76 118.99 117.01 109.57 12.38%
EPS 26.01 25.70 24.38 23.03 25.34 24.13 21.74 12.71%
DPS 18.50 18.50 17.50 17.50 17.50 17.50 14.50 17.65%
NAPS 1.47 1.39 1.35 1.29 1.37 1.31 1.29 9.10%
Adjusted Per Share Value based on latest NOSH - 138,872
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
RPS 18.93 18.40 17.85 17.43 17.16 16.88 15.81 12.76%
EPS 3.77 3.71 3.52 3.32 3.65 3.48 3.14 12.97%
DPS 2.67 2.67 2.53 2.53 2.53 2.53 2.09 17.75%
NAPS 0.2132 0.2006 0.195 0.1862 0.1976 0.189 0.1861 9.49%
Price Multiplier on Financial Quarter End Date
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Date 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 -
Price 3.88 2.50 3.17 2.97 3.03 2.58 2.55 -
P/RPS 2.97 1.96 2.57 2.46 2.55 2.20 2.33 17.57%
P/EPS 14.92 9.73 13.00 12.90 11.96 10.69 11.73 17.41%
EY 6.70 10.28 7.69 7.75 8.36 9.35 8.53 -14.88%
DY 4.77 7.40 5.52 5.89 5.78 6.78 5.69 -11.10%
P/NAPS 2.64 1.80 2.35 2.30 2.21 1.97 1.98 21.16%
Price Multiplier on Announcement Date
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Date 18/05/15 24/02/15 21/11/14 26/08/14 20/05/14 26/02/14 19/11/13 -
Price 3.90 2.92 3.01 3.37 3.09 2.60 2.56 -
P/RPS 2.99 2.29 2.44 2.79 2.60 2.22 2.34 17.77%
P/EPS 14.99 11.36 12.34 14.64 12.19 10.78 11.77 17.51%
EY 6.67 8.80 8.10 6.83 8.20 9.28 8.49 -14.87%
DY 4.74 6.34 5.81 5.19 5.66 6.73 5.66 -11.16%
P/NAPS 2.65 2.10 2.23 2.61 2.26 1.98 1.98 21.46%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment